Abbott Laboratories
- All
- News
- Videos
-
Major Producer Finishes India Recall Of US Imported Baby Formula Products
- Friday May 20, 2022
- India News | Reuters
Abbott Laboratories' India unit has completed a recall of baby formula products that were manufactured at the company's troubled Michigan facility in the United States, a spokesperson for the company said on Friday.
-
www.ndtv.com
-
India Looks To Lure More Than 1,000 US Companies Out Of China
- Thursday May 7, 2020
- India News | Archana Chaudhary, Bloomberg
India is seeking to lure US businesses, including medical devices giant Abbott Laboratories, to relocate from China as President Donald Trump's administration steps up efforts to blame Beijing for its role in the coronavirus pandemic.
-
www.ndtv.com
-
US Lab Unveils Portable 5-Minute Coronavirus Test
- Saturday March 28, 2020
- World News | Agence France-Presse
A US-based lab has unveiled a portable test that can tell if someone has COVID-19 in as little as five minutes, it said in a statement Friday.
-
www.ndtv.com
-
Not Just Stents. India Rejects US Request For Medical Devices Price Caps
- Tuesday May 1, 2018
- India News | Reuters
India has told the US it won't abstain from capping prices for more medical devices, regardless of pressure to rethink its stance after price controls on heart stents and knee implants spoilt the market for some US firms, sources familiar with the matter said
-
www.ndtv.com
-
India Caps Prices of 108 More Medicines; Drugmakers to Take Hit
- Monday July 14, 2014
- India News | Reuters
India's pharmaceutical pricing regulator has cut and capped the prices of more than 100 drugs used to treat diseases ranging from diabetes to HIV to malaria, a move likely to hit the profit margins of drug firms like Sanofi SA, Abbott Laboratories and Ranbaxy Laboratories Ltd.
-
www.ndtv.com
-
India rejects US company's patent for anti-HIV drugs
- Monday January 10, 2011
- India News | NDTV Correspondent
What serves as one of the biggest threats against people living with HIV AIDS is multinational drug companies, producing lifesaving drugs, pushing for patents so generic companies cannot produce them at much lower prices. However, in a much needed relief to Indian pharmaceutical companies as well as patients, India rejected a patent application fil...
-
www.ndtv.com
-
Major Producer Finishes India Recall Of US Imported Baby Formula Products
- Friday May 20, 2022
- India News | Reuters
Abbott Laboratories' India unit has completed a recall of baby formula products that were manufactured at the company's troubled Michigan facility in the United States, a spokesperson for the company said on Friday.
-
www.ndtv.com
-
India Looks To Lure More Than 1,000 US Companies Out Of China
- Thursday May 7, 2020
- India News | Archana Chaudhary, Bloomberg
India is seeking to lure US businesses, including medical devices giant Abbott Laboratories, to relocate from China as President Donald Trump's administration steps up efforts to blame Beijing for its role in the coronavirus pandemic.
-
www.ndtv.com
-
US Lab Unveils Portable 5-Minute Coronavirus Test
- Saturday March 28, 2020
- World News | Agence France-Presse
A US-based lab has unveiled a portable test that can tell if someone has COVID-19 in as little as five minutes, it said in a statement Friday.
-
www.ndtv.com
-
Not Just Stents. India Rejects US Request For Medical Devices Price Caps
- Tuesday May 1, 2018
- India News | Reuters
India has told the US it won't abstain from capping prices for more medical devices, regardless of pressure to rethink its stance after price controls on heart stents and knee implants spoilt the market for some US firms, sources familiar with the matter said
-
www.ndtv.com
-
India Caps Prices of 108 More Medicines; Drugmakers to Take Hit
- Monday July 14, 2014
- India News | Reuters
India's pharmaceutical pricing regulator has cut and capped the prices of more than 100 drugs used to treat diseases ranging from diabetes to HIV to malaria, a move likely to hit the profit margins of drug firms like Sanofi SA, Abbott Laboratories and Ranbaxy Laboratories Ltd.
-
www.ndtv.com
-
India rejects US company's patent for anti-HIV drugs
- Monday January 10, 2011
- India News | NDTV Correspondent
What serves as one of the biggest threats against people living with HIV AIDS is multinational drug companies, producing lifesaving drugs, pushing for patents so generic companies cannot produce them at much lower prices. However, in a much needed relief to Indian pharmaceutical companies as well as patients, India rejected a patent application fil...
-
www.ndtv.com